| Product NDC: | 25021-826 |
| Proprietary Name: | zoledronic acid |
| Non Proprietary Name: | zoledronic acid |
| Active Ingredient(s): | .04 mg/mL & nbsp; zoledronic acid |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 25021-826 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA203231 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130302 |
| Package NDC: | 25021-826-82 |
| Package Description: | 1 BAG in 1 CARTON (25021-826-82) > 100 mL in 1 BAG |
| NDC Code | 25021-826-82 |
| Proprietary Name | zoledronic acid |
| Package Description | 1 BAG in 1 CARTON (25021-826-82) > 100 mL in 1 BAG |
| Product NDC | 25021-826 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zoledronic acid |
| Dosage Form Name | LIQUID |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130302 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | ZOLEDRONIC ACID |
| Strength Number | .04 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |